Physician profile
David J Barber
NPI 1003309832
$1,495.26
in general payments reported to CMS, 2019-2025
21 companies · $284 in 2025
The $284 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.10 · 2020: $28.86 · 2021: $323 · 2022: $133 · 2023: $282 · 2024: $350 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $916.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $915.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $266.11 | 2023-2025 | Grafix Pl, Hat-Trick, Oasis |
| Salvin Dental Specialties, INC. | $241.02 | 2021 | |
| Paratek Pharmaceuticals, INC. | $142.45 | 2022-2025 | Nuzyra |
| Amgen INC. | $137.44 | 2024-2025 | Krystexxa |
| Nevro Corp. | $96.81 | 2022-2024 | Senza |
| Stryker Corporation | $79.76 | 2023-2024 | Citrefix, Na |
| Integra Lifesciences Corporation | $75.97 | 2019-2020 | |
| Treace Medical Concepts, INC. | $72.45 | 2022-2024 | |
| Ossur Americas, INC. | $49.79 | 2024-2025 | |
| Horizon Therapeutics Plc | $49.63 | 2023 | Krystexxa |
| Wright Medical Technology, INC. | $46.99 | 2019 | |
| Organogenesis INC. | $44.26 | 2021-2023 | Puraply |
| Tenex Health INC. | $37.65 | 2021 | |
| Medline Industries LP | $29.21 | 2021 | |
| Grt US Holding, INC. | $26.22 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $23.93 | 2024 | Activ.A.C. |
| Depuy Synthes Sales INC. | $20.43 | 2025 | |
| Fidia Pharma USA INC. | $20.09 | 2025 | |
| Sanara Medtech INC. | $14.85 | 2022 | |
| Heron Therapeutics, INC. | $14.00 | 2022 | |
| Next Science LLC | $6.20 | 2023 | Surgx, Xperience, Blastx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Barber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.